Farzan Nima insider trades
Farzan Nima has filed 9 Form 4s with the SEC that we hold, for Keros Therapeutics, Inc. (KROS) (Director) and KNTE (CHIEF EXECUTIVE OFFICER, Director). Across all of them we count 0 purchases worth $0 and 1 sale worth $28.2K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($28.2K). The largest single trade was a sale of 2,625 shares of Keros Therapeutics, Inc. worth $28.2K, dated 2026-06-04. The first filing on our record is dated 2022-02-15 and the latest 2026-06-08.
Keros Therapeutics, Inc. (KROS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-04 | S, sale reported on Form 4 | 2,625 | $28.2K | 2026-06-08 |
KNTE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1808296) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms